To ask the Secretary of State for Health, what measures were taken in awarding the contract for smallpox vaccines to Powderject, to ensure value for money. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, what measures were taken in awarding the contract for smallpox vaccines to Powderject, to ensure value for money. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, when (a) the first official contact between ministers in his Department and Powderject concerning the smallpox vaccine and (b) the signing of the contract was; and if he will make a statement. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, when (a) the first official contact between ministers in his Department and Powderject concerning the smallpox vaccine and (b) the signing of the contract was; and if he will make a statement. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, whether the smallpox vaccine ordered from Powderject will need to be trialled before it can be used.

To ask the Secretary of State for Health, whether the smallpox vaccine ordered from Powderject will need to be trialled before it can be used.

To ask the Secretary of State for Health, whether he was informed, at the time of signing the contract with Powderject, that (a) the manufacturing would be sub-contracted to a further company and (b) it would be undertaken outside the UK. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, whether he was informed, at the time of signing the contract with Powderject, that (a) the manufacturing would be sub-contracted to a further company and (b) it would be undertaken outside the UK. - (Holding answer 8 May 2002).

To ask the Secretary of State for Health, for what reasons the Powderject contract for smallpox vaccines was handled as a matter of national security; and if he will make a statement. - Ref to the answer given on 15 May 2002, 385 c727. (Holding answer 8 May 2002).

To ask the Secretary of State for Health, for what reasons the Powderject contract for smallpox vaccines was handled as a matter of national security; and if he will make a statement. - Ref to the answer given on 15 May 2002, 385 c727. (Holding answer 8 May 2002).

To ask the Secretary of State for Health, if Powderject has applied for a licence for the smallpox vaccine; and if such a licence was included in the specification provided by his Department.

To ask the Secretary of State for Health, if Powderject has applied for a licence for the smallpox vaccine; and if such a licence was included in the specification provided by his Department.

Why the smallpox vaccine to be manufactured in Germany by Bavarian Nordic was purchased through an intermediary rather than directly. [HL 4591].

Why the smallpox vaccine to be manufactured in Germany by Bavarian Nordic was purchased through an intermediary rather than directly. [HL 4591].

Which pharmaceutical companies they approached about the purchase of smallpox vaccine; and whether those companies included Bavarian Nordic [HL 3923].

Which pharmaceutical companies they approached about the purchase of smallpox vaccine; and whether those companies included Bavarian Nordic [HL 3923].

To ask the Secretary of State for Health, where the smallpox vaccine to be acquired under the contract with PowderJect Pharmaceuticals is to be manufactured; and which company will be responsible for its manufacture.

To ask the Secretary of State for Health, where the smallpox vaccine to be acquired under the contract with PowderJect Pharmaceuticals is to be manufactured; and which company will be responsible for its manufacture.

Whether they considered the use of the accelerated tendering procedures permitted by European Union procurement rules for the purchase of smallpox vaccines; and, if so, why those procedures were not adopted [HL 3979].

Whether they considered the use of the accelerated tendering procedures permitted by European Union procurement rules for the purchase of smallpox vaccines; and, if so, why those procedures were not adopted [HL 3979].

Further to the statement by Lord Hunt of Kings Heath that the procurement of smallpox vaccines fell outside the usual rules governing competitive tendering because the procurement concerns national security (18 April, 633 c1075), whether they regard the announcement by PowderJect Pharmaceuticals that it had been awarded a contract for...

Further to the statement by Lord Hunt of Kings Heath that the procurement of smallpox vaccines fell outside the usual rules governing competitive tendering because the procurement concerns national security (18 April, 633 c1075), whether they regard the announcement by PowderJect Pharmaceuticals that it had been awarded a contract for...

Whether the smallpox vaccine to be supplied by PowderJect Ltd will be produced in the United Kingdom [HL 3988].

Whether the smallpox vaccine to be supplied by PowderJect Ltd will be produced in the United Kingdom [HL 3988].

Business question on the contract awarded to Powderject for the smallpox vaccine.

Business question on the contract awarded to Powderject for the smallpox vaccine.

Whether, when they awarded the contract for smallpox vaccine to PowderJect Pharmaceuticals, they were aware that the company did not intend to manufacture the vaccine itself; and whether they approved the plan to sub-contract manufacture to Bavarian Nordic. [HL 3922].

Whether, when they awarded the contract for smallpox vaccine to PowderJect Pharmaceuticals, they were aware that the company did not intend to manufacture the vaccine itself; and whether they approved the plan to sub-contract manufacture to Bavarian Nordic. [HL 3922].

What was meant by the Prime Minister's statement, 383 c567, 17 April 2002, that "many companies were asked to tender" for the smallpox vaccine contract. [HL 3924].

What was meant by the Prime Minister's statement, 383 c567, 17 April 2002, that "many companies were asked to tender" for the smallpox vaccine contract. [HL 3924].

Whether they will be meeting the costs of clinical trials for smallpox vaccine to be supplied by PowderJect Pharmaceuticals; and, if so, how much these are expected to cost. [HL 3925].

Whether they will be meeting the costs of clinical trials for smallpox vaccine to be supplied by PowderJect Pharmaceuticals; and, if so, how much these are expected to cost. [HL 3925].

What previous government contracts have been awarded to PowderJect Pharmaceuticals; and what have been the outcomes of those contracts. [HL 3885].

What previous government contracts have been awarded to PowderJect Pharmaceuticals; and what have been the outcomes of those contracts. [HL 3885].

To ask the Secretary of State for Health, what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. - (Holding answer 28 February 2002).

To ask the Secretary of State for Health, what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. - (Holding answer 28 February 2002).

Supplementary business question on the contract awarded to PowderJect for the smallpox vaccine.

Supplementary business question on the contract awarded to PowderJect for the smallpox vaccine.